Acurx Pharmaceuticals ACXP Income Statement (2020-2026)

NASDAQ ACXP
$1.45 +0.01 (+0.69%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
0.51M0.51M0.51M0.51M0.58M0.58M0.58M0.65M0.65M0.72M0.79M0.80M0.84M0.85M1.12M1.19M1.80M1.50M2.72M4.68M
Operating items
Research & Development (Quarter)
1.13M0.72M0.82M0.91M1.59M1.43M1.02M1.74M1.35M1.94M1.56M1.83M1.20M0.83M0.60M0.52M0.43M0.28M0.34M1.07M
Selling, General & Administrative (Quarter)
3.52M1.91M1.85M1.71M1.95M1.83M1.89M1.71M1.77M3.17M2.82M2.30M1.63M1.97M1.58M1.75M1.60M1.34M1.37M1.24M
Operating Expenses (Quarter)
4.64M2.63M2.67M2.62M3.54M3.26M2.90M3.45M3.11M5.11M4.38M4.12M2.83M2.79M2.18M2.27M2.03M1.62M1.72M2.31M
Operating Income (Quarter)
-4.12M-2.83M-2.79M-2.18M-2.27M-2.03M-1.62M-1.72M-2.31M
EBIT (Quarter)
-4.12M-2.83M-2.79M-2.18M-2.27M-2.03M-1.62M-1.72M-2.31M
Non-operating items
Interest & Investment Income (Quarter)
782.000.01M0.01M0.03M0.02M0.04M0.04M0.04M0.05M
Net income details
EBT (Quarter)
-4.12M-2.82M-2.94M-2.15M-2.25M-1.99M-1.58M-1.68M-2.25M
Profit After Tax (Quarter)
-4.64M-2.63M-2.67M-2.62M-3.54M-3.26M-2.90M-3.45M-3.11M-5.11M-4.38M-4.12M-2.82M-2.78M-2.15M-2.25M-1.99M-1.58M-1.68M-2.25M
Income from Continuing Operations (Quarter)
-4.12M-2.82M-2.94M-2.15M-2.25M-1.99M-1.58M-1.68M-2.25M
Consolidated Net Income (Quarter)
-4.12M-2.82M-2.94M-2.15M-2.25M-1.99M-1.58M-1.68M-2.25M
Income towards Parent Company (Quarter)
-4.12M-2.82M-2.94M-2.15M-2.25M-1.99M-1.58M-1.68M-2.25M
Net Income towards Common Stockholders (Quarter)
-4.12M-2.82M-2.94M-2.15M-2.25M-1.99M-1.58M-1.68M-2.25M
Additional items
EPS (Basic) (Quarter)
-5.21-3.45-3.63-2.15-1.89-1.23-1.05-0.62-0.53
EPS (Diluted) (Quarter)
-5.21-3.45-3.63-2.15-1.89-1.23-1.05-0.62-0.53
Shares Outstanding (Quarter)
0.51M0.43M0.51M0.51M0.56M0.54M0.58M0.61M0.65M0.63M0.77M0.79M0.82M0.81M1.00M1.19M1.63M1.50M2.72M4.26M
Shares Outstanding (Diluted) (Quarter)
0.51M0.43M0.51M0.51M0.56M0.54M0.58M0.61M0.65M0.63M0.77M0.79M0.82M0.81M1.00M1.19M1.63M1.50M2.72M4.26M
EBITDA (Quarter)
-4.12M-2.83M-2.79M-2.18M-2.27M-2.03M-1.62M-1.72M-2.31M
Interest Expenses (Quarter)
2.85M7.11M0.02M0.25M0.15M